madman
Super Moderator
* This approach involves administering high doses of testosterone, which has shown significant improvement in 30% of patients, enhancing strength, energy, and sexual function
* their research uses blood-based DNA markers to predict which patients will respond best, aiming to personalize treatment and switch between high and low testosterone levels to prevent cancer resistance
Dr. Samuel Denmeade, an oncologist at Johns Hopkins, discusses bipolar androgen therapy, a novel treatment for prostate cancer patients resistant to standard hormone therapy. This approach involves administering high doses of testosterone, which has shown significant improvement in 30% of patients, enhancing strength, energy, and sexual function. Dr. Denmeade explains how their research uses blood-based DNA markers to predict which patients will respond best, aiming to personalize treatment and switch between high and low testosterone levels to prevent cancer resistance.
* their research uses blood-based DNA markers to predict which patients will respond best, aiming to personalize treatment and switch between high and low testosterone levels to prevent cancer resistance
Dr. Samuel Denmeade, an oncologist at Johns Hopkins, discusses bipolar androgen therapy, a novel treatment for prostate cancer patients resistant to standard hormone therapy. This approach involves administering high doses of testosterone, which has shown significant improvement in 30% of patients, enhancing strength, energy, and sexual function. Dr. Denmeade explains how their research uses blood-based DNA markers to predict which patients will respond best, aiming to personalize treatment and switch between high and low testosterone levels to prevent cancer resistance.
